Physician profile
Kenneth B Chapman
NPI 1366494262
$15,200.89
in general payments reported to CMS, 2019-2025
34 companies · $861 in 2025
The $861 reported for 2025 was more than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,131 · 2020: $759 · 2021: $4,906 · 2022: $1,324 · 2023: $2,056 · 2024: $3,164 · 2025: $861.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,053 · Entertainment: $27.67.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,053.05 |
| Entertainment | $27.67 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $6,671.66 | 2019-2024 | Proclaim, Eterna, Prodigy |
| Painteq LLC | $2,436.41 | 2021-2024 | Painteq |
| Boston Scientific Corporation | $1,369.14 | 2019-2025 | Wavewriter Alpha Prime 16 |
| Biotronik Nro, INC. | $703.99 | 2024-2025 | Prospera |
| Nalu Medical, INC. | $604.89 | 2021-2024 | Nalu Neurostimulation System |
| Vertos Medical, INC. | $576.77 | 2021-2023 | Mild Device Kit |
| Relievant Medsystems, INC. | $292.54 | 2021 | |
| Spinal Simplicity, LLC | $234.24 | 2023-2025 | Ha Minuteman G3-R |
| Forte Bio-Pharma LLC | $231.07 | 2024-2025 | Prolate, Nalocet, Tanlor |
| Saluda Medical Americas, INC. | $219.13 | 2022 | |
| Flowonix Medical Incorporated | $216.68 | 2019 | |
| Medtronic, INC. | $185.79 | 2022 | |
| Foundation Fusion Solutions, LLC | $166.25 | 2024 | |
| Mml US, INC. | $156.59 | 2025 | Reactiv8 |
| Medtronic USA, INC. | $149.82 | 2020 |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $136.40 | 2023 | Stimrouter Implantable Kit |
| Si-Bone, INC. | $134.13 | 2019-2025 | |
| Grt US Holding, INC. | $124.55 | 2021 | |
| Stimwave Technologies Incorporated | $92.50 | 2020 | |
| Scilex Pharmaceuticals INC. | $72.11 | 2025 | |
| Curonix LLC | $56.75 | 2024 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Abbvie INC. | $46.18 | 2022 | |
| Vertiflex, INC. | $43.55 | 2019 | |
| Ibsa Pharma INC. | $42.42 | 2023 | Tirosint, Licart |
| Merz Pharmaceuticals, LLC | $41.89 | 2024 | Xeomin |
| Depuy Synthes Sales INC. | $39.37 | 2019-2023 | Orthovisc |
| Collegium Pharmaceutical, INC. | $26.20 | 2020 | |
| Takeda Pharmaceuticals U.S.A., INC. | $21.54 | 2019 | |
| Nevro Corp. | $21.52 | 2019 | |
| Protega Pharmaceutials INC | $19.48 | 2024 | Roxybond |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $19.09 | 2024 | Relistor |
| Kowa Pharmaceuticals America, INC. | $17.88 | 2022 | |
| Biohaven Pharmaceutical Holding Company Ltd. | $17.83 | 2022 | |
| Virtus Pharmaceuticals LLC | $12.53 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kenneth Chapman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.